Skip to content

Menu

HomeAboutServices
Sean P. Wajert of Shook, Hardy & Bacon LLP logo
Contact
Subscribe
Search
Close
Published by Sean P. Wajert

Mass Tort Defense

Defense of Mass Tort Claims, Class Actions, and Significant Product-Based Litigation

ghostwriting

Subscribe to ghostwriting

PhRMA Issues New Principles on Clinical Trials

By Sean Wajert on October 7, 2009
Posted in Articles, Drug and Device

Readers of MassTortDefense know how the conduct and results of clinical trials can reach out and affect later product liability litigation: plaintiffs…
Continue Reading PhRMA Issues New Principles on Clinical Trials

Senator Writes Letter To NIH About “Ghostwriting”

By Sean Wajert on August 20, 2009
Posted in Articles, Drug and Device

Plaintiffs in pharmaceutical and other biomedical litigation have frequently resorted to allegations of “ghostwriting” to attack various a…
Continue Reading Senator Writes Letter To NIH About “Ghostwriting”

Published by
Sean P. Wajert
Phone: 215.278.2430
Fax: 215.278.2594
Email: swajert@shb.com
Add this blog to your RSS feeds Connect with me on LinkedIn Follow me on Twitter
Privacy PolicyDisclaimer

About My Practice

Mass Tort Defense Lawyer & Attorney Sean P. Wajert of Shook, Hardy & Bacon LLP, offering services relating to mass torts, product liability, class actions, medical monitoring, pharmaceutical litigation, consumer fraud act defense, complex litigation.

Read More...

Categories

Archives

Copyright © 2023, Sean P. Wajert of Shook, Hardy & Bacon LLP. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo